Skip to content
10-Q

Quarterly Report

CATALENT PHARMA SOLUTIONS, INC.

0001416083-13-000020

← back to feed
Filed
Nov 12, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Nov 1, 2013 100 sh
Capex Q1 2014 · Sep 30, 2013 $18.8M
Capex Q1 2014 · Sep 30, 2012 $24.6M
Operating Cash Flow Q1 2014 · Sep 30, 2013 $25.2M
Operating Cash Flow Q1 2014 · Sep 30, 2012 $12.1M
Long Term Debt Q1 2014 · Sep 30, 2013 $2.67B
Long Term Debt Q1 2014 · Jun 30, 2013 $2.66B
Cash And Equivalents Q1 2014 · Sep 30, 2013 $95.8M
Cash And Equivalents Q1 2014 · Jun 30, 2013 $106.4M
Cash And Equivalents Q1 2014 · Sep 30, 2012 $420.7M
Cash And Equivalents Q1 2014 · Jun 30, 2012 $139M
Stockholders Equity Q1 2014 · Sep 30, 2013 −$386.9M
Stockholders Equity Q1 2014 · Jun 30, 2013 −$410.7M
Current Liabilities Q1 2014 · Sep 30, 2013 $348.5M
Current Liabilities Q1 2014 · Jun 30, 2013 $410.3M
Current Assets Q1 2014 · Sep 30, 2013 $616.7M
Current Assets Q1 2014 · Jun 30, 2013 $677.9M
Total Assets Q1 2014 · Sep 30, 2013 $3.04B
Total Assets Q1 2014 · Jun 30, 2013 $3.06B
Sga Expense Q1 2014 · Sep 30, 2013 $81.1M
Sga Expense Q1 2014 · Sep 30, 2012 $81.8M
Net Income Q1 2014 · Sep 30, 2013 $1.5M
Net Income Q1 2014 · Sep 30, 2012 −$19.7M
Operating Income Q1 2014 · Sep 30, 2013 $35.1M
Operating Income Q1 2014 · Sep 30, 2012 $32.4M
Gross Profit Q1 2014 · Sep 30, 2013 $119.2M
Gross Profit Q1 2014 · Sep 30, 2012 $117.5M
Cost Of Revenue Q1 2014 · Sep 30, 2013 $295.1M
Cost Of Revenue Q1 2014 · Sep 30, 2012 $294.5M
Revenue Q1 2014 · Sep 30, 2013 $414.3M
Revenue Q1 2014 · Sep 30, 2012 $412M